Figure 1From: MRS-guided HDR brachytherapy boost to the dominant intraprostatic lesion in high risk localised prostate cancer Up: T2-weighted transverse MR image, with the MRSI grid and a color map corresponding to the choline/citrate ratio. Down: MRS spectra for respective voxels.Back to article page